Zobrazeno 1 - 10 of 453 pro vyhledávání: '"Michael T Tetzlaff"'
1
Akademický článek
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of nonmelanoma skin cancer
Autor: Christopher A Barker, Evan J Lipson, Harriet Kluger, Brian R Gastman, Michael T Tetzlaff, Igor Puzanov, Shailender Bhatia, Paul Nghiem, Ann W Silk, Zeynep Eroglu, Sunandana Chandra, Isaac Brownell, Anna C Pavlick, David M Miller, Vernon K Sondak, Kari L Kendra, Kathryn B Bollin, Kathleen Madden, Guilherme Rabinowits, Emily S Ruiz, Edward A Tavss
Publikováno v: Journal for ImmunoTherapy of Cancer, Vol 10, Iss 7 (2022)
Nonmelanoma skin cancers (NMSCs) are some of the most commonly diagnosed malignancies. In general, early-stage NMSCs have favorable outcomes; however, a small subset of patients develop resistant, advanced, or metastatic disease, or aggressive subtyp
Externí odkaz: https://doaj.org/article/2231699fe22649279195857fb8881112
Zobrazit plný text záznamu
2
Akademický článek
Immune profiling of uveal melanoma identifies a potential signature associated with response to immunotherapy
Autor: Wei-Lien Wang, Bita Esmaeli, Patrick Hwu, Alexandre Reuben, Michael T Tetzlaff, Jason Roszik, Mariana Petaccia De Macedo, Yong Qin, Kathryn Bollin, Fernando Carapeto, Kevin B Kim, Khalida M Wani, Sujan T Reddy, Michelle D Williams, Dan S Gombos, Alexander J Lazar, Sapna P Patel
Publikováno v: Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Background To date, no systemic therapy, including immunotherapy, exists to improve clinical outcomes in metastatic uveal melanoma (UM) patients. To understand the role of immune infiltrates in the genesis, metastasis, and response to treatment for U
Externí odkaz: https://doaj.org/article/3fed3b3cb79e42dfbf4d90c23d4d647c
Zobrazit plný text záznamu
3
Akademický článek
The Society for Immunotherapy of Cancer statement on best practices for multiplex immunohistochemistry (IHC) and immunofluorescence (IF) staining and validation
Autor: Ignacio I Wistuba, Michael T Tetzlaff, Carlo B Bifulco, Katharina von Loga, Sacha Gnjatic, Scott J Rodig, Janis M Taube, Keith E Steele, Marlon C Rebelatto, David L Rimm, Ana Lako, Edwin R Parra, Guray Akturk, Michael Angelo, Elizabeth L Engle, Shirley Greenbaum, Noah F Greenwald, Cyrus V Hedvat, Travis J Hollmann, Jonathan Juco, Jaime Rodriguez-Canales, Kurt A Schalper, Edward C Stack, Cláudia S Ferreira, Konstanty Korski, Emanuel Schenck, Michael J Surace
Publikováno v: Journal for ImmunoTherapy of Cancer, Vol 8, Iss 1 (2020)
Objectives The interaction between the immune system and tumor cells is an important feature for the prognosis and treatment of cancer. Multiplex immunohistochemistry (mIHC) and multiplex immunofluorescence (mIF) analyses are emerging technologies th
Externí odkaz: https://doaj.org/article/aa359e762b4f41ddb084a9f360b5fc80
Zobrazit plný text záznamu
4
Akademický článek
Molecular and immunological associations of elevated serum lactate dehydrogenase in metastatic melanoma patients: A fresh look at an old biomarker
Autor: Grant M. Fischer, Fernando C. L. Carapeto, Aron Y. Joon, Lauren E. Haydu, Huiqin Chen, Fuchenchu Wang, John S. Van Arnam, Jennifer L. McQuade, Khalida Wani, John M. Kirkwood, John F. Thompson, Michael T. Tetzlaff, Alexander J. Lazar, Hussein A. Tawbi, Jeffrey E. Gershenwald, Richard A. Scolyer, Georgina V. Long, Michael A. Davies
Publikováno v: Cancer Medicine, Vol 9, Iss 22, Pp 8650-8661 (2020)
ABSTRACT Elevated serum lactate dehydrogenase (sLDH) is associated with poor clinical outcomes in patients with stage IV metastatic melanoma (MM). It is currently unknown if sLDH elevation correlates with distinct molecular, metabolic, or immune feat
Externí odkaz: https://doaj.org/article/e32ea8c232ab4d4dbc418f18f9b8b609
Zobrazit plný text záznamu
5
Akademický článek
Granulomatous/sarcoid-like lesions associated with checkpoint inhibitors: a marker of therapy response in a subset of melanoma patients
Autor: Michael T. Tetzlaff, Kelly C. Nelson, Adi Diab, Gregg A. Staerkel, Priyadharsini Nagarajan, Carlos A. Torres-Cabala, Beth A. Chasen, Jennifer A. Wargo, Victor G. Prieto, Rodabe N. Amaria, Jonathan L. Curry
Publikováno v: Journal for ImmunoTherapy of Cancer, Vol 6, Iss 1, Pp 1-11 (2018)
Abstract Background Immune checkpoint therapy has dramatically changed the landscape of cancer therapy, providing an efficacious and durable therapeutic option for patients with advanced-stage disease. However, dermatologic toxicities are a well-reco
Externí odkaz: https://doaj.org/article/702c89c0e6e04f88a481332e31c49761
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje